Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 22,551–22,575 of 27,380 studies, newest first · page 903 of 1096.

July 2007 2

  1. 2007-07-01

    Donepezil preserves cognition and global function in patients with severe Alzheimer disease

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Patients with severe AD demonstrated greater efficacy compared to placebo on measures of cognition and global function. +2 more findings

  2. 2007-07-01

    Does NSAID use modify cognitive trajectories in the elderly? The Cache County study

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Nonsteroidal anti-inflammatory drug use may help to prevent cognitive decline in older adults if started in midlife rather than late life. +1 more finding

June 2007 23

  1. 2007-06-29

    Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment NeuroImage

    Key finding: Recent research has shown an increased rate of conversion to dementia in subjects with mild cognitive impairment (MCI) compared to controls. +4 more findings

  2. 2007-06-27

    Japanese version of the Frontal Assessment Battery for dementia

    ✓ Peer-reviewed Cognitive tests and assessment Psychiatry research

    Key finding: The purpose of this study was to evaluate the validity and reliability of a Japanese version of the FAB to measure cognitive dysfunction in patients with dementia. +3 more findings

  3. 2007-06-27

    Relation of cognitive activity to risk of developing Alzheimer disease

    ✓ Peer-reviewed Caregiving Neurology

    Key finding: Level of cognitively stimulating activity in old age is related to risk of developing dementia. +3 more findings

  4. 2007-06-25

    Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

    ✓ Peer-reviewed Biomarkers British journal of pharmacology

    Key finding: The results of the present study confirm in vivo anti-inflammatory actions of CBD, emphasizing the importance of this compound as a novel promising pharmacological tool capable of attenuating Abeta evoked neuroinflammatory responses. +1 more finding

  5. 2007-06-23

    Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain

    ✓ Peer-reviewed Lewy body dementia Medical image analysis

    Key finding: This study indicates that SyN, with cross-correlation, is a reliable method for normalizing and making anatomical measurements in volumetric MRI of patients and at-risk elderly individuals.

  6. 2007-06-20

    Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

    ✓ Peer-reviewed Getting a diagnosis Acta neuropathologica

    Key finding: Molecular genetic studies of familial cases of FTLD-U have shown that mutations in the progranulin (PGRN) gene are a major genetic cause of FTLD-U. +2 more findings

  7. 2007-06-19

    Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration

    ✓ Peer-reviewed Inflammation and the immune system Journal of neuroimmunology

    Key finding: However, their alteration during ageing and age-related diseases has not been thoroughly investigated yet. +3 more findings

  8. 2007-06-18
  9. 2007-06-15

    Oxysterols, cholesterol homeostasis, and Alzheimer disease

    ✓ Peer-reviewed Genetics Journal of neurochemistry

    Key finding: Oxysterol-mediated LXR activation induces local apoE biosynthesis (predominantly in astrocytes) further enhancing cholesterol re-distribution and removal. +4 more findings

  10. 2007-06-14

    Frontotemporal lobar degeneration: clinical and pathological relationships

    ✓ Peer-reviewed Brain tissue and pathology Acta neuropathologica

    Key finding: Clinical phenotype is often assumed to be a poor predictor of underlying histopathology. +3 more findings

  11. 2007-06-14

    Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies

    ✓ Peer-reviewed Risk factors American journal of epidemiology

    Key finding: Compared with those who never smoked, current smokers at baseline also showed greater yearly declines in Mini-Mental State Examination scores over the follow-up period (effect size (beta)=-0.13, 95% CI: -0.18, -0.08). +2 more findings

  12. 2007-06-13

    Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

    ✓ Peer-reviewed Genetics Free radical biology & medicine

    Key finding: Oxidative stress has been implicated to play a crucial role in the pathogenesis of a number of diseases, including neurodegenerative disorders, cancer, and ischemia, just to name a few. +4 more findings

  13. 2007-06-13
  14. 2007-06-07

    Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly

    ✓ Peer-reviewed Long-term cohort studies Psychosomatic medicine

    Key finding: Increasing frailty is associated with incident AD and the rate of cognitive decline in older persons. +4 more findings

  15. 2007-06-07

    {gamma}-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: IMPLICATIONS FOR ALZHEIMER DISEASE

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: These mutations lead to an increased Abeta42/Abeta40 ratio that correlates with the onset of disease. +3 more findings

  16. 2007-06-07

    Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: Three amino acid substitutions distinguish mouse and human A beta that might contribute to their differing properties in vivo. +3 more findings

  17. 2007-06-05

    Expression of APP pathway mRNAs and proteins in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Brain research

    Key finding: We hypothesized that sporadic AD may also be associated with changes in transcription of APP or its metabolic partners. +1 more finding

  18. 2007-06-04

    Forecasting the global burden of Alzheimer's disease

    ✓ Peer-reviewed How common it is Alzheimer s & Dementia

    Key finding: In 2006, the worldwide prevalence of Alzheimer's disease was 26.6 million. +4 more findings

  19. 2007-06-04

    Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: For most, it is unclear whether shifts from one state to another would be helpful or harmful. +3 more findings

  20. 2007-06 month only

    Atypical antipsychotics for the treatment of dementia-related behaviors: an update

    ✓ Peer-reviewed Treatments Medicine and health, Rhode Island

    Key finding: The evidence base, although incomplete, suggests that modest treatment effect sizes are offset by risk of considerable adverse effects. +4 more findings

  21. 2007-06-01

    Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group

    ✓ Peer-reviewed Health systems and care delivery Movement disorders : official journal of the Movement Disorder Society

    Key finding: There are no standardized diagnostic criteria for psychosis associated with Parkinson's disease (PDPsy). +3 more findings

  22. 2007-06-01

    NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

    ✓ Peer-reviewed Disease mechanisms Nature reviews. Neuroscience

    Key finding: The number and subunit composition of synaptic N-methyl-D-aspartate receptors (NMDARs) are not static, but change in a cell- and synapse-specific manner during development and in response to neuronal activity and sensory experience. +2 more findings

  23. 2007-06-01

    A genomic pathway approach to a complex disease: axon guidance and Parkinson disease

    ✓ Peer-reviewed Prevention and risk PLoS genetics

    Key finding: These findings could have important implications regarding the pathogenesis of PD.

Browse the library by subject, with the full score breakdown →